CAMP

Reports that name this provider

Psychedelic Treatment Quality in Brazil

Center for Advanced Psychedelic Medicine at UFRN. Conducted world's first randomized placebo-controlled psychedelic depression trial. Phase 2a vaporized DMT trial: 22-point mean MADRS score reduction from baseline to day 7 in treatment-resistant depression (14 patients). Leadership: Dráulio Araújo (director), Nicole Galvão-Coelho (associate director), Dr. Marcelo Falchi (medical director), Isabel Wießner (scientific director). Full neuroimaging, psychiatric scales, blood/saliva biological markers, ECG monitoring.